医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Amendment of Tender Offer Registration Statement for Benesse Holdings, Inc. (Securities Code: 9783) by Bloom 1 K.K.

2024年02月16日 PM03:15
このエントリーをはてなブックマークに追加


 

TOKYO

We hereby announce that Bloom 1 K.K. filed the attached Amendment of Tender Offer Registration Statement today.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240215925543/en/

(Attachment)
Amendment of Tender Offer Registration Statement for Benesse Holdings, Inc. (Securities Code: 9783) by Bloom 1 K.K. dated February 16, 2024

View source version on businesswire.com: https://www.businesswire.com/news/home/20240215925543/en/

CONTACT

KRIK (PR Agent)

Koshida: +81-70-8793-3990

Sugiyama: +81-70-8793-3989

同じカテゴリーの記事 

  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続
  • ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究
  • ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology